Resignation of Senior Management Personnel of the Company.

Management Changes View source PDF Explain this filing

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹30170.00

prior close

₹30195.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.7%+0.8% vs market

Pharmaceuticals peers, median of 154sector-0.8%+0.9% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Midcap 150 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-0.3

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1-0.7+0.8-0.8+0.9

Next day

-1.4-2.6+1.2-3.1+1.7

-1.7-2.3+0.6-3.2+1.5

-2.2-2.3+0.0-3.2+1.0

-1.0-1.4+0.4-2.4+1.5

-0.9-0.6-0.3-2.1+1.2

-1.0+0.5-1.5-2.9+2.0

15d

-1.2+1.2-2.4-3.5+2.3

-1.3+2.5-3.8-3.4+2.1

-0.4+2.8-3.2-7.0+6.6

-4.2+3.1-7.3-5.8+1.6

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Abbott India has informed the BSE that Mr. Munish Prashar, Plant Director of its Goa facility, has resigned from the company effective close of business hours on October 31, 2025. He is leaving to pursue an external career opportunity. Upon his exit, he will also cease to be classified as Senior Management Personnel of the company. The disclosure has been made under SEBI Listing Regulations, and his resignation letter has been enclosed with the filing. The company has not indicated any replacement or transition plan in this intimation.

Likely market impact

This is a routine senior-level operational departure and is unlikely to materially affect the stock price. Investors may want to watch for any successor announcement for the Goa Plant Director role, as continuity at a key manufacturing site is operationally relevant for the pharma business.